INTEGRATED BIOPHARMA INC (INBP)
2025-03-31 | 2024-09-30 | |||
|---|---|---|---|---|
| Sales, net | 13,947 | 13,617 | ||
| Cost of sales | 12,396 | 12,246 | ||
| Gross profit | 1,551 | 1,371 | ||
| Selling and administrative expenses | 812 | 881 | ||
| Operating income (loss) | 739 | 490 | ||
| Other income (expense), net | 34 | - | ||
| Interest income (expense), net | -5 | -14 | ||
| Other income (expense), net | 39 | - | ||
| Income (loss) before income taxes | 778 | 504 | ||
| Income tax expense, net | 167 | 245 | ||
| Net income (loss) | 611 | 259 | ||
| Basic eps | 0.02 | 0.01 | ||
| Diluted eps | 0.02 | 0.01 | ||
| Basic average shares | 30,300,720 | 30,099,610 | ||
| Diluted average shares | 31,514,591 | 30,649,977 | ||